Klp Kapitalforvaltning As Rocket Pharmaceuticals, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 15,300 shares of RCKT stock, worth $151,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,300Holding current value
$151,164% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
224Shares Held
94.8MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$175 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$111 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$65 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$61.2 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$46.6 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $748M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...